FDA approved semaglutide medications are indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with conditions such as type 2 diabetes, hypertension, or dyslipidemia
Differences between groups were analyzed using ANOVA and Mann-Whitney U test
Improved regularity in PCOS: Women with polycystic ovary syndrome may notice more regular cycles as insulin sensitivity improves with weight loss
While fasting, exercise requires extra care when taking medication, as it already affects energy levels and how the body processes fuel
For research, this transition from needle to pill is precisely the methodologically compelling point
Once tirzepatide therapy begins, schedule follow-up TSH testing every 36 months during the first year, then annually if stable, because dose adjustments to either medication may be needed